National Bank Of Canada Qiagen N.V. Transaction History

National Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$35.55 - $43.57 $100,215 - $122,823	2,819 Added 17.36%	19,055 $827,000
Q3 2023 Oct 10, 2023	SELL	$39.13 - $47.24 $2.56 Million - $3.09 Million	-65,409 Reduced 80.11%	16,236 $657,000
Q2 2023 Jul 26, 2023	BUY	$43.93 - $46.76 $873,020 - $929,261	19,873 Added 32.17%	81,645 $3.68 Million
Q1 2023 Apr 12, 2023	BUY	$45.29 - $50.76 $2.8 Million - $3.14 Million	61,772 New	61,772 $2.84 Million
Q3 2022 Oct 13, 2022	BUY	$40.9 - $50.42 $629,614 - $776,165	15,394 Added 52.88%	44,503 $2.48 Million
Q2 2022 Jul 28, 2022	BUY	$42.98 - $49.77 $844,986 - $978,478	19,660 Added 208.06%	29,109 $1.62 Million
Q1 2022 May 05, 2022	BUY	$42.23 - $54.3 $399,031 - $513,080	9,449 New	9,449 $527,000

6.34M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.1B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.